Meeting site. Photo courtesy of the organizer.
In order to promote the development of immunology and strengthen the exchange of new technologies in life sciences, on December 2, the 3rd National Immunology New Technology Exchange Conference and the 2023 Academic Annual Conference of Chongqing Immunology Society were held in Chongqing.
At the scene, immunology experts from many places across the country gathered in Shancheng to jointly develop new technologies, new concepts and new methods of immunology medicine, and provide new ideas and new momentum for the high-quality development of immunology medicine.
The Department of Rheumatology and Immunology of the Children's Hospital of Chongqing Medical University has long led the construction of IEI diagnosis, prevention, screening, research and promotion system in China. In the keynote sharing and exchange session, Professor Zhao Xiaodong from the hospital shared the latest progress and thinking of IEI research with the guests around the theme of "Research Progress Related to Immune Birth Error (IEI)", combined with experimental data and cases, hoping to achieve early detection and early detection with the help of continuous innovation and breakthroughs in science and technology, so as to save the lives of children.
Professor Jin Aishun from Chongqing Medical University focused on the research and development and application of new immune prevention and treatment technologies, combined with his own basic and translational research in the field of tumor immunity for more than ten years, and introduced the current research and development and transformation of immune prevention and treatment technologies, including the research and development of fully human antibody technology, the development and transformation of antibody drugs, and TCR-T cell immunity**.
Next, Professor Lu Lu from the School of Basic Medical Sciences of Fudan University shared the research and development strategies of universal influenza vaccines, the research ideas of immune enhancement technologies of new biomimetic strategies, and the research results of broad-spectrum vaccines for emerging viruses around the "Research on Antiviral Broad-spectrum Vaccines Based on Immune Enhancement Technology".
Professor Ye Lilin from the Army Medical University introduced the presence of tumor antigen-specific memory CD8+ T cells in tumor drainage lymph nodes with "T cell exhaustion and memory" as the starting point, and the key role of this group of cells in PD-1 ICB**.
Professor Chen Yongwen, also from the Army Medical University, also shared with the guests the clinical digital decoding model of pathological classification, molecular classification, immunity assessment, and immunity scoring.
It is worth mentioning that Professor Qin Chengfeng from the Academy of Military Medicine of the Academy of Military Sciences also shared the theme of "mRNA Technology Responds to Pandemics: From Vaccines to Antibodies". "An mRNA vaccine is a biological product that delivers mRNA encoding a protective antigen to the body through a specific delivery system, so that the body can obtain immune protection. Qin Chengfeng said that in order to better respond to the next pandemic, in addition to strengthening zoonotic disease surveillance and carrying out global pathogen sequencing, it is also particularly important to quickly produce vaccines and strengthen production capacity to interrupt transmission.
The antigen target selection of mRNA vaccines is more accurate, the localization of production capacity can be rapidly scaled, the cold chain cost is low, and it is easy to achieve large-scale population vaccination. Qin Chengfeng said.